New hope for rare heart disease: trial tests drug to halt damage

NCT ID NCT03593317

Summary

This study is testing whether a medication called spironolactone can slow the progression of a rare heart muscle disease called ARVD. It will involve 120 patients in France who will take either the drug or a placebo for three years. The goal is to see if the drug can reduce heart damage and dangerous irregular heartbeats, potentially improving quality of life and reducing hospital visits.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Amiens Picardie

    NOT_YET_RECRUITING

    Amiens, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • CHU Dijon

    RECRUITING

    Dijon, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Groupe Hospitalo Universitaire Caremeau

    NOT_YET_RECRUITING

    Nîmes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Arnaud de Villeneuve

    RECRUITING

    Montpellier, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Cardiologique Louis Pradel

    RECRUITING

    Bron, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Gabriel Montpied

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Laennec

    RECRUITING

    Nantes, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Michallon

    NOT_YET_RECRUITING

    Grenoble, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital Pitié Salpetrière

    RECRUITING

    Paris, France

    Contact

    Contact Email: •••••@•••••

  • Hôpital Rangueil

    NOT_YET_RECRUITING

    Toulouse, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital de Haut-Lévêque

    NOT_YET_RECRUITING

    Pessac, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hôpital de la Timone

    NOT_YET_RECRUITING

    Marseille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Nouvel Hôpital Civil

    NOT_YET_RECRUITING

    Strasbourg, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.